These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7828189)

  • 1. High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study.
    Schoenen J; Lenaerts M; Bastings E
    Cephalalgia; 1994 Oct; 14(5):328-9. PubMed ID: 7828189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medium-dose riboflavin as a prophylactic agent in children with migraine: a preliminary placebo-controlled, randomised, double-blind, cross-over trial.
    Bruijn J; Duivenvoorden H; Passchier J; Locher H; Dijkstra N; Arts WF
    Cephalalgia; 2010 Dec; 30(12):1426-34. PubMed ID: 20974610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic treatment of migraine with beta-blockers and riboflavin: differential effects on the intensity dependence of auditory evoked cortical potentials.
    Sándor PS; Afra J; Ambrosini A; Schoenen J
    Headache; 2000 Jan; 40(1):30-5. PubMed ID: 10759900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial.
    Schoenen J; Jacquy J; Lenaerts M
    Neurology; 1998 Feb; 50(2):466-70. PubMed ID: 9484373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs.
    Di Lorenzo C; Pierelli F; Coppola G; Grieco GS; Rengo C; Ciccolella M; Magis D; Bolla M; Casali C; Santorelli FM; Schoenen J
    Neurology; 2009 May; 72(18):1588-94. PubMed ID: 19414726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial.
    Gaul C; Diener HC; Danesch U;
    J Headache Pain; 2015; 16():516. PubMed ID: 25916335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Riboflavin prophylaxis in pediatric and adolescent migraine.
    Condò M; Posar A; Arbizzani A; Parmeggiani A
    J Headache Pain; 2009 Oct; 10(5):361-5. PubMed ID: 19649688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized double-blind placebo-controlled trial of thioctic acid in migraine prophylaxis.
    Magis D; Ambrosini A; Sándor P; Jacquy J; Laloux P; Schoenen J
    Headache; 2007 Jan; 47(1):52-7. PubMed ID: 17355494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose riboflavin for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial.
    MacLennan SC; Wade FM; Forrest KM; Ratanayake PD; Fagan E; Antony J
    J Child Neurol; 2008 Nov; 23(11):1300-4. PubMed ID: 18984840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose riboflavin as a prophylactic treatment.
    Montagna P
    Cephalalgia; 1994 Oct; 14(5):317. PubMed ID: 7828185
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prophylactic treatments of migraine].
    Massiou H
    Rev Neurol (Paris); 2000; 156 Suppl 4():4S79-86. PubMed ID: 11139754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimizing migraines.
    Health News; 1998 Mar; 4(4):6. PubMed ID: 9553609
    [No Abstract]   [Full Text] [Related]  

  • 13. CoEnzyme Q10 and riboflavin: the mitochondrial connection.
    Markley HG
    Headache; 2012 Oct; 52 Suppl 2():81-7. PubMed ID: 23030537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial.
    Maizels M; Blumenfeld A; Burchette R
    Headache; 2004 Oct; 44(9):885-90. PubMed ID: 15447697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cinnarizine in migraine prophylaxis: efficacy, tolerability and predictive factors for therapeutic responsiveness. An open-label pilot trial.
    Rossi P; Fiermonte G; Pierelli F
    Funct Neurol; 2003; 18(3):155-9. PubMed ID: 14703897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of low-dose riboflavin as a prophylactic agent in pediatric migraine.
    Yamanaka G; Suzuki S; Takeshita M; Go S; Morishita N; Takamatsu T; Daida A; Morichi S; Ishida Y; Oana S; Nara S; Shimura M; Nishimata S; Kawashima H
    Brain Dev; 2020 Aug; 42(7):523-528. PubMed ID: 32336482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study.
    Krymchantowski AV; Barbosa JS
    Cephalalgia; 2002 May; 22(4):309-12. PubMed ID: 12100094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.
    Pfaffenrath V; Diener HC; Fischer M; Friede M; Henneicke-von Zepelin HH;
    Cephalalgia; 2002 Sep; 22(7):523-32. PubMed ID: 12230594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre.
    Boehnke C; Reuter U; Flach U; Schuh-Hofer S; Einhäupl KM; Arnold G
    Eur J Neurol; 2004 Jul; 11(7):475-7. PubMed ID: 15257686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of lamotrigine in the prophylaxis of migraine with aura: an open pilot study.
    D'Andrea G; Granella F; Cadaldini M; Manzoni GC
    Cephalalgia; 1999 Jan; 19(1):64-6. PubMed ID: 10099862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.